用遗传证据和索赔数据库对偏头痛药物重新定位的综合分析
Shoichiro Inokuchi1, Takumi Tajima1
1Real World Evidence Division, Pharmaceutical Division, JMDC Inc., Tokyo, Japan.
Frontiers in big data
|December 8, 2025
概括
这项研究通过将遗传数据与药物概况和索赔数据相结合,确定了潜在的偏头痛治疗方法. 甲胺,他类药物和其他药物在减少偏头痛发作频率方面表现有前途.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
- 遗传学 遗传学 是一个
背景情况:
- 偏头痛是一种常见的神经疾病,具有重大社会经济影响.
- 遗传因素在偏头痛的发展中起着至关重要的作用,需要基于基因的治疗点识别.
- 现有的偏头痛治疗方法需要进一步开发,突出显示需要新的治疗策略.
研究的目的:
- 确定新的治疗点和偏头痛治疗候选药物.
- 整合全基因组关联研究 (GWAS) 数据,扰动物概况和药物重新定位的索赔数据.
- 评估已识别的化合物在减少急性偏头痛频率方面的临床疗效.
主要方法:
- 利用全转录组关联研究 (TWAS) 来从GWAS数据中归因基因表达特征.
- 与LINCS连接地图的扰动物配置文件进行交叉引用,以识别潜在的候选药物.
- 采用现实世界索赔数据库和队列研究设计来评估已识别的扰动剂对急性偏头痛药物处方频率的影响.
主要成果:
- 根据干扰物概况,确定了18种已批准的药物作为潜在的偏头痛治疗药物.
- 现实世界的数据分析表明,甲福明,他类药物, thiazolidines 和血管激素受体 neprilysin 抑制剂可以减少偏头痛发作.
- 甲福明的相对风险 (RR) 为0.81 (95% CI:0.77-0.86),而血管新生素受体不普利辛抑制剂的相对风险 (RR) 为0.69 (95% CI:0.61-0.77) 的偏头痛发作.
结论:
- 综合遗传学,药理学和现实世界的临床数据的多学科方法为偏头痛药物重新定位提供了具有成本效益的框架.
- 这项研究提供了一种新的策略,用于识别用于偏头痛治疗的重用药物.
- 这些发现支持甲胺,他类药物, thiazolidines 和血管激素受体 neprilysin 抑制剂在治疗偏头痛方面的潜力.
相关概念视频
01:09Bioequivalence of Drugs: Drugs with Multiple Indications
141
The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each...
141
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
382
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
382
02:46Genetic Screens
5.6K
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
5.6K
01:28Structure-Activity Relationships and Drug Design
1.7K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.7K